Precision AQ

What's in a name? A lot if you ask us. Introducing: Precision AQ. It's a nod to our mission, empowering access to life-changing medicine for all, but also our approach. IQ + EQ = Precision Access Quotient (AQ). We've fused together the science 🧪 (IQ) and empathy ❤️ (EQ) of nine diverse organizations into one brand to offer greater access to the services, data, expertise, and scale needed to navigate the therapy-to-patient journey. Learn more about our new blueprint for access: https://lnkd.in/gvB9eCJh

Even as a therapy enters the “late lifecycle,” medical affairs teams can’t slow down. Continuing to empower access to medicine years after launch can look like: ⚫ Continued evidence generation ⚫ Demonstrating the value against generic competition ⚫ Exploring broader use applications Ross Maclean, Head of Medical Affairs, and Uchenna Iloeje, MD share why and how med affairs teams can drive “safe and appropriate use” activities forward in a feature for Healthcare Business Today: https://lnkd.in/ei5Dhmgn #pharmaindustry #marketaccess #biopharma

It’s been a great month for Pride at Precision. We asked colleagues to snap selfies showing their pride, and for every picture submitted we made a donation to the The Trevor Project, a leading organization dedicated to ending suicide among LGBTQ+ youth, and to IGLA Europe, which fights for LGBTI equality and human rights across Europe and Central Asia. It’s another way we highlight support for our LGBTQIA+ friends, colleagues, and family members around the world. #Pride #PrideMonth #pride2024 #TrevorProject #IGLAEurope

Pharma manufacturers are stepping up to help patients afford their medications through patient assistance programs (PAPs). But how can companies ensure these programs truly benefit patients? Enabling access to life-changing medicine requires effective PAPs. Learn to tailor your PAPs, measure success, and navigate market factors with insights from our team - Lauren Westberg, EVP, Managing Director, Courtney L. Ottoson, SVP, Director of Client Services, and Andrew Cournoyer, SVP, Director of Access Experience Team – in MMIT (Managed Markets Insight & Technology): https://lnkd.in/ePb8uuWa #PAPs #patientexperience #patientaccess #healthequity

ASCO 2024 brought together thousands of minds and voices in oncology and life sciences. We captured the essence of these conversations to highlight pivotal moments and trends that defined the event. From groundbreaking research to inspiring stories, see what everyone was talking about online. Get our social listening report: https://lnkd.in/e4yi8_8Y #ASCO2024 #oncology #lifesciences #insights

"If you had the power to stop a disease before it started, you would, wouldn’t you?" Cynthia Miller, MD, MPH, CPH, FACP, VP, Medical Director and advocate for preventive care services, speaks about newfound research on lipid management medications on MedCity News. With support from healthcare providers, doctors, pharmaceutical companies, and EHR vendors, we could be on the brink of decreasing the development of and mortality from cardiovascular disease. https://lnkd.in/gZURVVUg

Does anyone want to be reminded of their own mortality? No. But if someone is suffering from a disease, illness or life-changing condition, do they need hope? Yes. See how Marinella Georgino, SVP, Executive Creative Director, strikes the delicate balance between hope and reality in medical marketing over on PharmaLive. https://lnkd.in/em9uSr-k

Can you guess the most talked about cancer type at ASCO 2024? The Precision AQ team delved into the discussions from the annual meeting, pinpointing the key topics that caught everyone’s attention. 👀 Check out the full report: https://lnkd.in/e4yi8_8Y #ASCO2024 #oncology #lifescience #sociallistening

One word: inspiring! Our team gathered in NYC for MM+M's Women of Distinction celebration last week, surrounded by remarkable healthcare leaders and changemakers. Highlight of the day? Celebrating Charline Shan, RPh, MPH, our VP of Strategic Consulting! Congratulations to all the 2024 honorees. #MMMWomenofDistinction #womeninhealthcare #leadership

Advanced therapies offer patients with schizophrenia greater hope for recovery. But to experience a better future, medication adherence is necessary. Maureen Hennessey, PhD, CPCC, CPHQ, SVP, Director of Value Transformation, teamed up with Ashley Son, Program Manager of Stanford Health Care and Elizabeth Oyekan, PharmD, FCSHP, CPHQ, Chief Pharmacy Officer of Stanford Health Care, to outline patient-centered approaches for the health care ecosystem to enhance adherence and recovery among persons with schizophrenia. They have practical suggestions for patients and their support systems traveling a journey towards better well-being. Read the full article on AJMC - The American Journal of Managed Care: https://lnkd.in/eue9St39 #mentalhealthawareness #schizophrenia